StayCurrentMD · Re: Safety and short-term efficacy of mirabegron in children with valve bladder: a pilot study
Article1 min read·Published Apr 2022Older

Re: Safety and short-term efficacy of mirabegron in children with valve bladder: a pilot study

link.springer.com shows its articles on its own site.

Read the article on link.springer.com ↗

Article · Apr 2022 · 1 min read

In brief

In brief

Pilot study evaluating mirabegron safety and short-term efficacy in pediatric patients with valve bladder and overactive bladder symptoms. The research examines pharmacological intervention within the stepwise treatment approach recommended by ICCS, following urotherapy as first-line management.

Written by the GCMD Library team from the article.

Abstract

Overactive bladder (OAB) is a common lower urinary tract dysfunction syndrome. A stepwise approach is a prudent choice. Urotherapy is recommended by the International Children’s Continence Society (ICCS) as the first-line treatment for OAB.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →